Find information on thousands of medical conditions and prescription drugs.

Hemolytic-uremic syndrome

In medicine, hemolytic-uremic syndrome (or haemolytic-uraemic syndrome, abbreviated HUS) is a disease characterised by microangiopathic hemolytic anemia, acute renal failure and a low platelet count (thrombocytopenia). more...

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Signs and symptoms

The classic case of HUS occurs after bloody diarrhea caused by E. coli O157:H7, a strain of E. coli that expresses verotoxin (also called Shiga toxin). The toxin enters the bloodstream, attaches to renal endothelium and initiates an inflammatory reaction leading to acute renal failure (ARF) and diffuse intravascular coagulation (DIC). The fibrin mesh destroys red blood cells and captures thrombocytes, leading to a decrease of both on full blood count.

HUS occurs after 2-7% of all E. coli O157:H7 infections.

Diagnosis

Clinically, HUS can be very hard to distinguish from thrombotic thrombocytopenic purpura (TTP). The laboratory features are almost identical, and not every case of HUS is preceded by diarrhea. The only distinguishing feature is that in TTP, neurological symptoms occur more often, but this is not always the case.

Treatment

Treatment is generally supportive with dialysis as needed. Platelet transfusion may actually worsen outcome. Mortality of HUS is 3-5%.

Often, plasmapheresis is also initiated, when there is diagnostic uncertainty between HUS and TTP.

Prognosis

About one-third of persons with hemolytic-uremic syndrome have abnormal kidney function many years later, and a few require long-term dialysis. Another 8% of persons with hemolytic uremic syndrome have other lifelong complications, such as high blood pressure, seizures, blindness, paralysis, and the effects of having part of their bowel removed.

Impact on society

HUS and the E. Coli infections which caused it have been the source of much negative publicity for the FDA, meat industries, and fast-food restaurants since the 1990's, especially in the Jack in the Box contaminations. It was also featured in the Robin Cook novel Toxin.

Read more at Wikipedia.org


[List your site here Free!]


Home-prepared hamburger and sporadic hemolytic uremic syndrome, Argentina - Letters - Letter to the Editor
From Emerging Infectious Diseases, 9/1/03 by Marta Rivas

To the Editor: Argentina has the highest incidence of hemolytic uremic syndrome (HUS) in the world, and 10.4 cases per 100,000 children <5 years of age were reported in 2001. HUS is the leading cause of acute renal failure in children (1); in 20% to 35% chronic renal failure develops, ranging from mild to serious, and HUS is the second leading cause of chronic renal failure (2,3) in Argentina. Recently, evidence of Shiga toxin--producing Escherichia coli (STEC) infection was found in 59% of Argentine HUS cases; 0157:H7 was the predominant serotype isolated (4). Although outbreaks of E. coli O157:H7 have been linked to eating contaminated ground beef (5), the organism is rarely isolated from the implicated meat, and the sources of infection for sporadic cases have rarely been identified. We report a sporadic HUS case linked to the consumption of home-prepared hamburger contaminated with E. coli O157.

A 2-year-old girl was brought to the emergency room of' the Hospital National de Pediatria "Prob. Dr. Juan Garrahan" in Buenos Aires on April 26, 2002, with a 1-day history of bloody diarrhea. Results of a physical examination were normal, and a stool culture was requested. The patient was sent home with dietary and general instructions. As watery diarrhea persisted with vomiting and fever, the girl was brought in again 3 days later. At that time, she exhibited moderate dehydration, pallor, drowsiness, and a generalized seizure of 10 to 15 min duration, tachycardia, tender and tense abdominal wall, and a history of oligoanuria for the last 48 h. Blood pressure was 128/67 mm Hg. The child was hospitalized with a presumptive diagnosis of HUS and anuric renal failure.

Initial laboratory findings included the following: hematocrit, 26%; hemoglobin level, 8.8 g/dL; leukocyte count, 34,800/[mm.sup.3]; segmented neutrophil count, 29,928/[mm.sup.3]; platelet count, 91,000/[mm.sup.3]; serum glucose, 160 mg/dL; blood urea nitrogen (BUN), 268 mg/dL; serum creatinine, 6.3 mg/dL; albumin, 1.7 g/dL; uric acid, 14.8 mg/dL; calcium, 6.9 mg/dL; phosphorus, 6.7 mg/dL; magnesium, 2.0 mg/dL; sodium, 113 mEq/L; potassium, 7.6 mEq/L; pH 7.28; bicarbonate, 10 mmol/L; base excess, -14.9 mmol/L. Chest x-ray findings were normal with a cardiothoracic index of 0.5; results of an abdominal sonogram were normal. A sonogram of the renal system also showed that the kidneys were of normal shape and size and had increased echogenicity. Results of a brain scan showed nonspecific brain atrophy.

The clinical findings and the laboratory features of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure were consistent with the diagnosis of HUS. The patient remained anuric for 17 days, required 17 peritoneal dialysis procedures, and six infusions of packed red blood cells. One month after the acute period, she had elevated BUN and serum creatinine levels and massive proteinuria.

The rectal swab sample collected on April 26 was routinely cultured for E. coli, Salmonella, Shigella, Yersinia, Aeromonas, Plesiomonas, Vibrio, and Campylobacter species. Sorbitol nonfermenting colonies were recovered on sorbitol-MacConkey (SMAC) agar (Difco Laboratories, Detroit, MI) and SMAC supplemented with cefixime (50 ng/mL) and potassium tellurite (25 mg/mL) (CT-SMAC). The bacterial confluent growth zones of both SMAC and CT-SMAC were positive for stx2 and rfbO157 genes by multiplex polymerase chain reaction (PCR) using the primers described by Pollard et al. (6) and Paton et al. (7), respectively. The E. coli O157 isolates were identified by standard biochemical methods and serologic tests by using specific O157 antiserum (INPB-ANLIS "Dr. Carlos G. Malbran") and sent to the Servicio Fisiopatogenia as National Reference Laboratory (NRL) for further characterization.

As part of the case-control study conducted in the pediatric hospital to identify the risk factors associated with the STEC infection, parents of the 2-year-old girl were interviewed with a standardized questionnaire 8 days after onset of symptoms. Information was collected about her clinical illness, potential exposures in the 7 days before the onset of diarrhea, and demographic issues. Her parents reported that on April 25 the girl had eaten a home-prepared hamburger, made from ground beef purchased from a local market. No other family members reported diarrhea.

Three days after the interview, on May 6, a formal complaint was presented by the mother at the Division of Public Health of Lanus, in the southern area of Buenos Aires, where the family lives. The frozen leftover ground beef from the same package used to make the hamburgers was provided by the child's family and processed at the Laboratorio Central de Salud Publica.

A 65-g portion of' the ground beef was incubated overnight at 42[degrees]C in 585 mL of modified E. coli medium broth containing novobiocin (final concentration, 20 [micro]g/mL). The sample was positive using the E. coli O157 Visual Immunoassay (Tecra International Pty. Ltd., French Forest NSW, Australia) (8). Immunomagnetic separation was performed with 1 mL of the culture, according to the instructions of the manufacturer Dynal, Inc., Oslo, Norway). The concentrate sample was plated onto CT SMAC and O157:H7 ID medium (bioMerieux, Marcy l'Etoile, France). Up to 20 sorbitol-nonfermenting colonies were selected, confirmed as E. coli O157, and sent to NRL.

At NRL, both clinical and ground beef O157 isolates were confirmed as E. coli O157:H7, susceptible to all of the antibiotics assayed, as previously described (9). Genotypic characterization showed that the isolates harbored stx2, eae, and EHEC-hlyA genes.

To establish their clonal relatedtess, the strains were assayed by subtyping methods (9). The identity of he strains was confirmed by the unique pulsed-field gel electrophoresis (PFGE) pattern with the restriction enzymes XbaI and AvrII, and the same phage type 4. In addition, both strains were characterized as stx2/stx2vh-a by PCR-restriction fragment length polymorphism.

To our knowledge, this is the first HUS case in our country in which the source of infection was identified. No investigation was conducted to trace back the source of the ground beef. This study illustrates the importance of the surveillance of STEC infections and the usefulness of molecular subtyping techniques, such as PFGE and phage typing, to determine the relatedness of strains and assess epidemiologic associations.

The public should be made aware that hamburgers, even when prepared at home, can be a source of infection. A primary strategy for preventing infection with E. coli O157:H7 is reducing risk behaviors through consumer education (10).

Acknowledgments

We thank Patricia Griffin for her review and helpful comments on earlier draft.

This work was supported by grants from Centers for Disease Control and Prevention (USA) and Fundacion Alberto J. Roemmers (Argentina).

References

(1.) Comite de Nefrologia de la Sociedad Argentina de Pediatria. Incidencia del sindrome uremico hemolitico (SUH) en la Republica Argentina. Arch Arg Pediatr 1995;93:409-11.

(2.) Gianantonio CA, Vitacco M, Mendilaharzu F, Rutty A, Mendilaharzu J. The hemolyticuremic syndrome. J Pediatr 1964;64:478-91.

(3.) Spizzirri FD, Rahman RC, Bibiloni N, Ruscasso JD, Amoreo OR. Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features. Pediatr Nephrol 1997;11:156-60.

(4.) Miliwebsky ES, Balbi L, Gomez D. Wainsztein R, Cueto Rua M, Roldan C, et al. Sindrome uremico hemolitico en ninos de Argentina: asociacion con la infeccion por Escherichia coli productor de toxina Shiga. Bioq Patol Clin 1999;63:113-21.

(5.) Griffin PM, Tauxe R. The epidemiology of infections caused by Escherichia coli O157:17, other enterohemorrhagic E. coli and the associated hemolytic uremic syndrome. Epidemiol Rev 1991:13:60-98.

(6.) Pollard DR, Johnson WM, Lior H, Tyler SD, Rozee KR. Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction. J Clin Microbiol 1990;28:540-5.

(7.) Paton A. Paton J. Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. J Clin Microbiol 1998;36:598-602.

(8.) Heuvelink AE, Zwartkruis-Nahuis JTM, De Boer E. Evaluation of media and test kits for the detection and isolation of Escherichia coli O157 from minced beef. J Food Prot 1997;60:817-24.

(9.) Chinen I, Tanaro JD, Miliwebsky E, Lound LH, Chillemi G, Ledri S, et al. Isolation and characterization of Escherichia coli O157:H7 from retail meats in Argentina. J Food Prot 2001;64:1346-51.

(10.) Griffin PM, Mead P, Sivapalasingam S. Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, editors. Infections of the gastrointesinal tract, 2nd edition. Philadelphia: Lippincott Williams and Wilkins; 2002. p.627-42.

Address for correspondence: Marta Rivas, Servicio Fisiopatogenia, Instituto National de Enfermedades Infecciosas-ANLIS "Dr. Carlos G. Malbran," Av. Velez Sarsfield 563 (1281), Buenos Aires, Argentina; Fax: +54-11-4303-1801; email: mrivas@anlis.gov.ar

Marta Rivas, * Maria Gracia Caletti, ([dagger]) Isabel Chinen, * Stella Maris Refi, ([double dagger]) Carlos Daniel Roldan, ([dagger]) German Chillemi, * Graciela Fiorilli, ([dagger]) Alicia Bertolotti, ([doube dagger]) Lorena Aguerre, * and Sergio Sosa Estani ([section])

* Instituto National de Enfermedades Infecciosas-ANLIS "Dr. Carlos G. Malbran," Buenos Aires, Argentina.; ([dagger]) Hospital Nacional de Pediatria "Prof. Dr. Juan Garrahan," Buenos Aires, Argentina; ([double dagger]) Laboratorio Central de Salud Publica, La Plata, Argentina; and ([section]) Centro Nacional de Diagnostico e Investigacion en Endemoepidemias-ANLIS "Dr. Carlos G. Malbran," Buenos Aires, Argentina

COPYRIGHT 2003 U.S. National Center for Infectious Diseases
COPYRIGHT 2003 Gale Group

Return to Hemolytic-uremic syndrome
Home Contact Resources Exchange Links ebay